about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesInfiltrative CardiomyopathiesIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesMetal Nanomaterial Toxicity Variations Within the Vascular SystemAge-dependent expression of duodenal cytochrome b, divalent metal transporter 1, ferroportin 1, and hephaestin in the duodenum of ratsIn situ imaging of metals in cells and tissuesFe²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe²⁺ influx.Iron overload cardiomyopathy: better understanding of an increasing disorder.Effect of heterozygous beta-thalassaemia trait on coronary atherosclerosis via coronary artery disease risk factors: a preliminary study.Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade.Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia PatientsIron and peripheral arterial disease: revisiting the iron hypothesis in a different light.Iron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation.Non transferrin bound iron: nature, manifestations and analytical approaches for estimationRole of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy.High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease.The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses.Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?Decreasing effects of iron toxicosis on selenium and glutathione peroxidase activity.Investigations into the systemic production of aldehyde-derived peroxidation products in a murine model of acute iron poisoning: a dose response study.Hepcidin in Iron Homeostasis: Diagnostic and Therapeutic Implications in Type 2 Diabetes Mellitus Patients.
P2860
Q24289511-CCA80398-941F-45C5-B84D-DF5A96A42EA2Q26798533-66B71613-66DF-4C2D-8427-C4BF015D42C0Q28388335-151C44AF-F1B6-438A-ABE7-88D143B7750FQ28394244-8CD70907-6280-4A24-985D-0D540B332525Q28566133-5C3D0FC0-307A-4ECF-BD0D-01D0E5C25CE0Q28662002-44CAEACC-3BCB-4B7E-85FB-E148CE42E6ACQ30416140-192822AD-D125-429E-A4F8-A34F9AB23F93Q34165921-0624AA02-815A-4640-B31A-036C1889E1D8Q34424222-47ACE214-8E05-4BCA-9892-14160BC0C3CCQ35414513-C9F515EB-80B6-42AC-9A68-876732AE67B8Q35665822-3CCF44EC-7F7B-4660-BE51-4D9C8341D6A3Q35677941-8530ECE6-8C0C-458F-9976-698ECB372D46Q36107259-0B62E859-6143-4E9C-88CB-00CBB5B14CC0Q36336362-1A2BA698-764D-4E9F-B02F-252E7795A466Q36444526-311DA729-CF88-44CC-893B-088B6EB997AEQ37369954-69C557E4-A68E-40BC-9F3D-1AD2E929ED66Q38200693-0D8C4032-FCA7-403D-8FDE-B2999F606F4FQ38311768-528330D9-60CF-494D-824A-C1806167A9FBQ43891123-1C5EC35A-32C2-483B-9489-19C88C4625DFQ44215783-A7A72EE0-E9DE-4584-BB61-28AE12D38921Q46261579-49563BE5-3133-4705-9AC5-15D620F23FB3
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Iron-mediated cardiovascular injury.
@ast
Iron-mediated cardiovascular injury.
@en
type
label
Iron-mediated cardiovascular injury.
@ast
Iron-mediated cardiovascular injury.
@en
prefLabel
Iron-mediated cardiovascular injury.
@ast
Iron-mediated cardiovascular injury.
@en
P2860
P1433
P1476
Iron-mediated cardiovascular injury.
@en
P2093
E A Rosenthal
L D Horwitz
P2860
P356
10.1177/1358836X9900400207
P577
1999-01-01T00:00:00Z